ЛИТЕРАТУРА
1. Кит О.И., Карнаухов Н.С., Новикова Е.А., Трифанов В.С. и др. Скрининг нейроэндокринного компонента в раке желудка // Современные проблемы науки и бразования. 2016. № 5.
2. Кит О.И. Нейроэндокринные, клинические и морфологические аспекты рака елудка. Новочеркасск: Лик, 2014. 187 с.
3. Clift A.K., Frilling A. Management of patients with hepatic metastases from neuroendocrine umors // Ann. Saudi Med. 2014. Vol. 34, N 4. P. 279-290.
4. Eadens M.J., Grothey A. Curable metastatic colorectal cancer // Curr. Oncol. Rep 2011. ol. 13, N 3. P. 168-176.
5. Frankel T.L., D’Angelica M.I. Hepatic resection for colorectal metastases // J. Surg.Oncol. 2014. Vol. 109, N 1. P. 2-7.
6. Galizia M.S., Töre H.G., Chalian H. Evaluation of hepatocellular carcinoma size using two-dimensional and volumetric analysis: effect on liver transplantation eligibility // Acad. adiol. 2011. Vol. 18, N 12. P. 1555-1560.
7. Kit O.I., Trifanov V.S., Novikova I.A., Todorov S.S., Clinical, pathological, and immunohistochemical features of pancreatic neuroendocrine tumors // J. Clin. Oncol.
2017. Vol. 34, N 3. P. 151-159.
8. Monsky W.L., Garza A.S., Kim I. Treatment planning and volumetric response assessment or Yttrium-90 radioembolization: semiautomated determination of liver volume and volume of tumor necrosis in patients with hepatic malignancy // Cardiovasc. Intervent. Radiol. 2011. Vol. 34, N 2. P. 306-318.
9. O’Dorisio T.M., Anthony L.B. A 25-year experience of gastroenteropancreatic neuroendocrine tumors and somatostatin (congeners) analogs: from symptom control to antineoplastic therapy // Front. Horm. Res. 2015. Vol. 44. P. 177-192.
10. Rahbari N., Mehrabi A., Mollberg N. et al. Hepatocellular carcinoma: current management nd perspectives for the future // Ann. Surg. 2011. Vol. 253. P. 453-469.